Eterna Therapeutics Inc. (ERNA)
undefined
undefined%
At close: undefined
0.33
-0.57%
Pre-market Jan 08, 2025, 06:09 AM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15
Net Income -21.67M -24.58M -122.31M -7.29M -2.05M -259.00K -1.08M -2.92M -7.23M
Depreciation & Amortization 1.12M 497.00K 459.00K 98.00K 3.17M 2.76M 2.32M 2.89M 3.10M
Stock-Based Compensation 1.24M 2.94M 5.24M 91.00K n/a n/a n/a n/a n/a
Other Working Capital 254.00K 1.68M -1.69M -994.00K -795.00K -2.01M 2.64M -318.00K -2.54M
Other Non-Cash Items 1.01M -3.54M 86.12M 19.24M 7.24M 6.92M 10.05M 6.66M 6.94M
Deferred Income Tax n/a n/a 9.35M -19.24M n/a n/a n/a n/a n/a
Change in Working Capital -2.12M 3.71M -2.35M -999.00K -37.00K -2.27M -1.73M -571.00K -1.67M
Operating Cash Flow -20.41M -20.98M -23.49M -8.10M 2.74M 1.36M 549.00K 23.00K -4.18M
Capital Expenditures -19.00K -297.00K -154.00K -39.00K -1.09M -1.61M -1.45M -840.00K -1.63M
Acquisitions n/a 250.00K -22.71M n/a 29.00K 33.00K n/a n/a 9.00K
Purchase of Investments n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies n/a 250.00K 119.00K n/a n/a n/a n/a n/a n/a
Investing Cash Flow -19.00K -47.00K -22.74M -39.00K -1.06M -1.58M -1.45M -840.00K -1.62M
Debt Repayment 16.50M -2.00K -942.00K 310.00K n/a -1.65M -3.23M 583.00K n/a
Common Stock Repurchased n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid -16.00K -16.00K -8.00K n/a -16.00K -16.00K -16.00K -16.00K n/a
Other Financial Acitivies -251.00K -109.00K 10.00K n/a -1.08M -17.00K n/a -3.00K 1.98M
Financial Cash Flow 16.56M 19.58M 61.59M 4.67M -1.10M -303.00K -1.47M 3.26M 1.98M
Net Cash Flow -3.87M -1.44M 15.36M -3.47M 673.00K -792.00K -2.31M 2.44M -3.82M
Free Cash Flow -20.43M -21.27M -23.64M -8.14M 1.65M -247.00K -903.00K -817.00K -5.81M